CHICAGO, Oct. 13 -- NAVTEQ, the leading global provider of digital map, traffic
GRASP uses spatial analysis tools to support a number of critical CDC initiatives, including the analysis of public health issues and GIS support for emergency operations centers. The GRASP spatial tools require accurate and comprehensive map data coverage to ensure reliable and accurate results are delivered to the CDC user community. As a result of NAVTEQ map data, the CDC will be to geocode for disease surveillance, hazardous substance tracking, and report on a variety of issues including workplace injury, drinking water safety and birth defects.
“We are excited to win this opportunity to support the critical mission of CDC within the United States Federal Government,” says Roy Kolstad, vice president, Enterprise Americas, NAVTEQ. “This award by CDC recognizes NAVTEQ’s ability to provide the most accurate, complete and comprehensive map coverage available in the industry.”
NAVTEQ map data includes geospatial information such as roads, cities, political boundaries, physical features, places, railroads, census boundaries, parks, schools, fire departments, police departments, and hospitals and many other geospatial vector data layers of important value to the CDC geospatial program.
NAVTEQ is the leading global provider of digital map, traffic and location data that enables navigation and location-based platforms around the world. NAVTEQ supplies comprehensive digital map information to power automotive navigation systems, portable and wireless devices, Internet-based mapping applications and government and business solutions. The Chicago-based company was founded in 1985 and has approximately 4,400 employees located in 192 offices and in 43 countries.
NAVTEQ is a trademark in the U.S. and other countries. All rights reserved.
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Inborn errors of metabolism are genetic disorders that hamper the body''s metabolism resulting in ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All